ETX-018810

· Eliem Therapeutics (UK) Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ETX-018810, covering 2023-05-16 to 2023-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain [Phase 2]